Insider

Regeneron Pharmaceuticals insiders traded shares on November 3 and 4

On November 3 and 4, 2026, Regeneron Pharmaceuticals insiders reported option exercises, share sales, and gifts. Director Huda Y. Zoghbi and vice president and controller Jason Pitofsky exercised options and sold shares, while co-chief scientific officer Andrew J. Murphy gifted shares.

Verified against 3 archived primary sources · SHA-256 recorded Inspect sources & citations ↓
a room filled with lots of tables and stools
Photo by Lusia Komala Widiastuti on Unsplash
$7,219,274.38
Huda Y. Zoghbi sale
$3,827,159.46
Jason Pitofsky sale
$2,833,887.05
Huda Y. Zoghbi exercise

Key points

  • On November 3, 2026, director Huda Y. Zoghbi exercised options for 7,439 shares worth $2,833,887.05.
  • Co-chief scientific officer Andrew J. Murphy gifted 1,054 shares on November 3, 2026.
  • The filed forms do not indicate the use of a Rule 10b5-1 trading plan, a preset selling schedule executives set up in advance.

Director and executive transactions

On November 3, 2026, director Huda Y. Zoghbi exercised options for 7,439 shares worth $2,833,887.05. That same day, she sold 7,439 shares for a total of $7,219,274.38.

On November 4, 2026, vice president and controller Jason Pitofsky exercised options for 3,883 shares worth $2,487,685.12. He also sold 4,062 shares for a total of $3,827,159.46.

Value of shares sold

Huda Y. Zoghbi sale$7,219,274.38Jason Pitofsky sale$3,827,159.46
Data from the original sources listed alongside.

Other events

Co-chief scientific officer Andrew J. Murphy gifted 1,054 shares on November 3, 2026.

Cautionary note on selling plans

The filed forms do not indicate the use of a Rule 10b5-1 trading plan, a preset selling schedule executives set up in advance. This neither confirms nor denies the existence of such a schedule, so insider motives for the trade dates remain unknown.

Next steps for shareholders

Investors should monitor future insider transaction reports published after any change in executive ownership.

Original sources

  1. 4 filing, November 5, 2026November 5, 2026SHA-256 of our archived copy 7b2fd4998596…
  2. 4 filing, November 5, 2026November 5, 2026SHA-256 of our archived copy deede98985a1…
  3. 4 filing, November 6, 2026November 6, 2026SHA-256 of our archived copy 156665418a51…
Cite this article

The fingerprint identifies the exact version of each original that the article was written from; the original stays at its source.

Prepared by AI from official company documents; automatic checks and an AI editor review it before publication, and not every article is read by a person. This is not investment advice. Editorial standards